HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara Romanowski Selected Research

Infections

10/2016Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
1/2016Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study.
1/2016Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.
10/2015Management of gonococcal infection among adults and youth: New key recommendations.
7/2015Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
4/2015Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
12/2014Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
10/2014Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.
8/2014Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.
12/2012Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara Romanowski Research Topics

Disease

16Infections
10/2016 - 04/2006
10Uterine Cervical Dysplasia
10/2016 - 04/2006
7Papillomavirus Infections
05/2016 - 01/2012
6Persistent Infection
10/2016 - 04/2006
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016 - 03/2011
4Neoplasms (Cancer)
01/2016 - 01/2012
3Atypical Squamous Cells of the Cervix
10/2016 - 08/2014
3Papilloma (Papillomatosis)
04/2015 - 01/2012
2Condylomata Acuminata (Genital Wart)
01/2016 - 11/2013
2Herpes Genitalis (Genital Herpes)
03/2005 - 03/2003
1Squamous Intraepithelial Lesions
10/2016
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
12/2012
1Adenocarcinoma in Situ
01/2012
1Coinfection
01/2012
1Communicable Diseases (Infectious Diseases)
03/2009
1Bacterial Vaginosis
05/2003
1Vaginal Discharge
05/2003

Drug/Important Bio-Agent (IBA)

14VaccinesIBA
10/2016 - 04/2006
5Papillomavirus Vaccines (HPV Vaccines)IBA
05/2016 - 03/2011
4AntibodiesIBA
01/2016 - 03/2011
4DNA (Deoxyribonucleic Acid)IBA
07/2015 - 03/2005
2Synthetic Vaccines (Recombinant Vaccines)IBA
08/2011 - 03/2011
2EnzymesIBA
03/2011 - 05/2003
1Azithromycin (Zithromax)FDA LinkGeneric
10/2015
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
10/2015
1Anti-Bacterial Agents (Antibiotics)IBA
10/2015
1Hormones (Hormone)IBA
10/2014
1Biomarkers (Surrogate Marker)IBA
01/2012
1Adenosine Triphosphate (ATP)IBA
01/2012
1ImmunosorbentsIBA
03/2011
1Combined VaccinesIBA
02/2011
1AntigensIBA
03/2005
1Neuraminidase (Sialidase)IBA
05/2003
1Coloring Agents (Dyes)IBA
05/2003
1Valacyclovir (Valtrex)FDA LinkGeneric
03/2003

Therapy/Procedure

2Therapeutics
10/2015 - 03/2003
1Hormonal Contraception
12/2012
1Intramuscular Injections
08/2011
1Aftercare (After-Treatment)
03/2009